Decipher Prostate
A 22-gene test on the biopsy or surgical specimen that predicts spread and death, used to decide on surveillance or adding hormone therapy.
Validated on NRG/RTOG 9601, 0126, 9902 cohorts; NCCN level-1 evidence; predicts benefit from ADT with radiation in some analyses. Basis of Decipher-stratified trials (NRG GU009/010). Complemented and challenged by ArteraAI Prostate (digital pathology).
Trials
topRecruiting now (live from ClinicalTrials.gov)
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"Decipher Prostate" OR ABSTRACT:"Decipher Prostate") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Decipher Prostate, not a curated reading list.
Pages like this
not linked directly; found by shared links- PairingAI pathology → androgen deprivation duration
Shares ArteraAI Prostate, Prostate cancer.
- TermGleason score / Grade Group
Shares Active surveillance, Prostate cancer.
- PersonAmar U. Kishan
Shares ArteraAI Prostate, Prostate cancer.
- TechnologyThyroid nodule FNA, Bethesda cytology & molecular classifiers
Shares Veracyte (Decipher), RNA sequencing & expression profiling.
- CompanyArtera
Shares ArteraAI Prostate, Prostate cancer.
- PersonArul M. Chinnaiyan
Shares RNA sequencing & expression profiling, Prostate cancer.
- TrialProtecT
Shares Active surveillance, Prostate cancer.
- TechnologyMultiparametric prostate MRI (PI-RADS)
Shares Active surveillance, Prostate cancer.